Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura, Thrombotic Thrombocytopenic | 5 | 2014 | 11 | 1.070 |
Why?
|
| Platelet Activating Factor | 4 | 2007 | 8 | 1.000 |
Why?
|
| ADAM Proteins | 3 | 2012 | 14 | 0.940 |
Why?
|
| Apolipoprotein A-I | 5 | 2012 | 68 | 0.770 |
Why?
|
| Plasma Exchange | 1 | 2014 | 10 | 0.560 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2014 | 7 | 0.560 |
Why?
|
| Oxymorphone | 1 | 2014 | 9 | 0.560 |
Why?
|
| Mass Spectrometry | 3 | 2006 | 90 | 0.440 |
Why?
|
| Neutrophils | 4 | 2007 | 105 | 0.430 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 2008 | 1 | 0.390 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 8 | 0.380 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 4 | 0.380 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2007 | 84 | 0.370 |
Why?
|
| Heart Diseases | 1 | 2008 | 112 | 0.350 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2006 | 2 | 0.340 |
Why?
|
| Blood Coagulation Disorders | 1 | 2006 | 10 | 0.340 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 40 | 0.330 |
Why?
|
| Myocardium | 1 | 2008 | 241 | 0.330 |
Why?
|
| Hematoma | 1 | 2006 | 23 | 0.330 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 18 | 0.330 |
Why?
|
| Myocardial Infarction | 2 | 2008 | 485 | 0.320 |
Why?
|
| Clinical Chemistry Tests | 1 | 2004 | 1 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2004 | 5 | 0.290 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 15 | 0.290 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 12 | 0.290 |
Why?
|
| Thrombosis | 1 | 2004 | 66 | 0.280 |
Why?
|
| Humans | 21 | 2014 | 29288 | 0.270 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 257 | 0.260 |
Why?
|
| Cholesterol | 4 | 2012 | 246 | 0.230 |
Why?
|
| Membrane Microdomains | 2 | 2012 | 25 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2012 | 60 | 0.220 |
Why?
|
| Autoimmunity | 2 | 2010 | 27 | 0.210 |
Why?
|
| Lipoproteins, HDL | 2 | 2012 | 271 | 0.190 |
Why?
|
| Mixed Function Oxygenases | 2 | 2008 | 12 | 0.170 |
Why?
|
| Male | 9 | 2014 | 18658 | 0.170 |
Why?
|
| Diet, Atherogenic | 3 | 2011 | 62 | 0.160 |
Why?
|
| Female | 9 | 2014 | 18970 | 0.160 |
Why?
|
| Obesity | 1 | 2003 | 1104 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 117 | 0.150 |
Why?
|
| Middle Aged | 6 | 2014 | 11572 | 0.150 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 20 | 0.140 |
Why?
|
| Atherosclerosis | 2 | 2011 | 790 | 0.130 |
Why?
|
| Adult | 4 | 2014 | 8719 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 537 | 0.130 |
Why?
|
| Plasmapheresis | 1 | 2012 | 9 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 512 | 0.120 |
Why?
|
| Macrophages | 2 | 2010 | 172 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 2012 | 64 | 0.120 |
Why?
|
| Immunosuppression | 1 | 2012 | 82 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2011 | 49 | 0.120 |
Why?
|
| Recurrence | 1 | 2012 | 237 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 55 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 16 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 23 | 0.110 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 35 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 186 | 0.110 |
Why?
|
| Plasmids | 2 | 2008 | 46 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2011 | 704 | 0.100 |
Why?
|
| Methods | 1 | 2008 | 6 | 0.100 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2008 | 4 | 0.100 |
Why?
|
| von Willebrand Factor | 1 | 2008 | 17 | 0.100 |
Why?
|
| Troponin I | 1 | 2008 | 17 | 0.100 |
Why?
|
| Necrosis | 1 | 2008 | 58 | 0.100 |
Why?
|
| Automation | 1 | 2008 | 29 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2008 | 56 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 24 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2009 | 57 | 0.090 |
Why?
|
| Factor VII | 1 | 2008 | 5 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2008 | 2981 | 0.090 |
Why?
|
| Acetyltransferases | 2 | 2005 | 2 | 0.090 |
Why?
|
| Protein Engineering | 1 | 2008 | 17 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 48 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 37 | 0.090 |
Why?
|
| Risk Factors | 2 | 2008 | 3732 | 0.090 |
Why?
|
| Copper | 1 | 2007 | 10 | 0.090 |
Why?
|
| Lipids | 2 | 2010 | 225 | 0.090 |
Why?
|
| Echocardiography | 1 | 2008 | 160 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2005 | 133 | 0.090 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2007 | 27 | 0.090 |
Why?
|
| Deuterium | 1 | 2007 | 9 | 0.090 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 14 | 0.090 |
Why?
|
| Calibration | 1 | 2007 | 23 | 0.090 |
Why?
|
| Isotope Labeling | 1 | 2007 | 18 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 32 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 27 | 0.080 |
Why?
|
| Young Adult | 1 | 2014 | 2427 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2005 | 256 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 162 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 16 | 0.080 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 6 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 48 | 0.080 |
Why?
|
| DNA Primers | 1 | 2006 | 91 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2006 | 79 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2006 | 82 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 724 | 0.080 |
Why?
|
| Base Sequence | 1 | 2006 | 238 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 267 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 38 | 0.080 |
Why?
|
| Mice | 5 | 2011 | 2366 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3173 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 340 | 0.080 |
Why?
|
| Vitamin K | 1 | 2005 | 9 | 0.080 |
Why?
|
| Factor IX | 1 | 2005 | 8 | 0.080 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 10 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2003 | 488 | 0.070 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 34 | 0.070 |
Why?
|
| Glycerophospholipids | 1 | 2004 | 1 | 0.070 |
Why?
|
| Osmotic Pressure | 1 | 2005 | 11 | 0.070 |
Why?
|
| Chromatography | 1 | 2004 | 4 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 66 | 0.070 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 3 | 0.070 |
Why?
|
| Thrombocytosis | 1 | 2004 | 1 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2004 | 8 | 0.070 |
Why?
|
| Catalysis | 1 | 2004 | 58 | 0.070 |
Why?
|
| Pyridines | 1 | 2005 | 89 | 0.070 |
Why?
|
| Factor VIII | 1 | 2004 | 14 | 0.070 |
Why?
|
| Phenotype | 1 | 2006 | 666 | 0.070 |
Why?
|
| Imidazoles | 1 | 2005 | 118 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 101 | 0.070 |
Why?
|
| Animals | 7 | 2011 | 7552 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2004 | 281 | 0.070 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2002 | 2 | 0.060 |
Why?
|
| Receptors, Eicosanoid | 1 | 2002 | 3 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2003 | 307 | 0.060 |
Why?
|
| Time Factors | 2 | 2009 | 2105 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2005 | 259 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 63 | 0.060 |
Why?
|
| Factor V | 1 | 2002 | 7 | 0.060 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2002 | 75 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2002 | 33 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 47 | 0.060 |
Why?
|
| Continental Population Groups | 1 | 2003 | 248 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 90 | 0.060 |
Why?
|
| Sex Factors | 1 | 2003 | 699 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2002 | 241 | 0.050 |
Why?
|
| Lipoproteins, LDL | 2 | 2011 | 73 | 0.050 |
Why?
|
| Aorta | 2 | 2011 | 116 | 0.050 |
Why?
|
| Receptors, LDL | 2 | 2010 | 63 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 77 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2010 | 25 | 0.050 |
Why?
|
| Lymph Nodes | 2 | 2010 | 92 | 0.050 |
Why?
|
| Aged | 3 | 2008 | 10068 | 0.050 |
Why?
|
| Stroke | 1 | 2004 | 545 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 458 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2010 | 603 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 241 | 0.040 |
Why?
|
| Cell Line | 2 | 2008 | 432 | 0.040 |
Why?
|
| Ceramides | 1 | 2012 | 8 | 0.030 |
Why?
|
| Sphingomyelins | 1 | 2012 | 8 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2012 | 80 | 0.030 |
Why?
|
| Biological Transport | 1 | 2012 | 64 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2012 | 89 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 35 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 104 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 37 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 6 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 82 | 0.030 |
Why?
|
| Triglycerides | 1 | 2011 | 225 | 0.030 |
Why?
|
| Protein Transport | 1 | 2010 | 78 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2010 | 74 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 40 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2010 | 74 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2010 | 173 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 100 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2010 | 62 | 0.030 |
Why?
|
| Gene Expression | 1 | 2011 | 340 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 184 | 0.030 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2009 | 2 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2011 | 793 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 2011 | 220 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2009 | 42 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 83 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 211 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 149 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 74 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 69 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 429 | 0.020 |
Why?
|
| DNA | 1 | 2009 | 207 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 43 | 0.020 |
Why?
|
| Transfection | 1 | 2008 | 185 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 101 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 523 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 13 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 35 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 743 | 0.020 |
Why?
|
| Cricetinae | 1 | 2005 | 62 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 43 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1040 | 0.020 |
Why?
|
| Kidney | 1 | 2008 | 481 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2002 | 5 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 10 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2002 | 15 | 0.020 |
Why?
|
| Calcimycin | 1 | 2002 | 5 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2002 | 5 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2002 | 9 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 39 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 45 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2002 | 26 | 0.020 |
Why?
|
| Rats | 1 | 2008 | 1750 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 25 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 167 | 0.020 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 3 | 0.020 |
Why?
|
| Indoles | 1 | 2002 | 64 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 21 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2002 | 17 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 88 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 99 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 68 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 121 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 84 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2002 | 102 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 312 | 0.010 |
Why?
|
| Synapses | 1 | 2002 | 85 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 255 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 839 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 456 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 466 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 492 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 938 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 425 | 0.010 |
Why?
|